Sou Hu Cai Jing·2025-07-22 02:07Core Insights - The first batch of semi-annual reports from Shenzhen Stock Exchange was released on July 21, showcasing positive performance from four companies, excluding *ST Lingda, indicating resilience and growth potential in a complex operating environment [1] Company Performance - Wohua Pharmaceutical achieved a net profit growth of 303.16%, leading the group, with a revenue of 425 million yuan, up 7.64% year-on-year [4][3] - Changchuan Technology reported a revenue of 2.167 billion yuan, a 41.80% increase, and a net profit growth of 98.73%, with R&D investment reaching 577 million yuan, accounting for 26.65% of revenue [4][3] - Ruihu Mould's revenue reached 1.662 billion yuan, up 48.30%, with a net profit increase of 40.33%, supported by strong orders in automotive manufacturing equipment [5][3] - Jucan Optoelectronics achieved record highs in revenue and net profit, with figures of 1.594 billion yuan and 117 million yuan, respectively, reflecting year-on-year growth of 19.51% and 3.43% [5][3] Strategic Focus - Wohua Pharmaceutical emphasizes refined management and a strategy of "reducing costs while increasing sales, efficiency, and cash flow" [4] - Changchuan Technology has established strong relationships with major integrated circuit manufacturers, laying a solid foundation for future growth [4] - Ruihu Mould is expanding its automotive lightweight components business, with production capacity gradually being released [5] - Jucan Optoelectronics is focusing on deepening its main business and advancing fine management, with ongoing projects to enhance product offerings [5]